Farzad Nazem - Jun 9, 2021 Form 3 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Director
Signature
/s/ Anna Mowry, as Attorney-in-Fact
Stock symbol
NAUT
Transactions as of
Jun 9, 2021
Transactions value $
$0
Form type
3
Date filed
6/9/2021, 09:38 PM
Next filing
Jun 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NAUT Common Stock 1.89M Jun 9, 2021 By HAND Capital, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NAUT Stock Option (Right to Buy) Jun 9, 2021 Common Stock 36.3K $10.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by HAND Capital, LLC. The reporting person is the manager of HAND Capital, LLC.
F2 Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through the applicable vesting date, one hundred percent (100%) of the shares subject to the Option shall vest on the earlier of (a) the one (1) year anniversary of the Vesting Commencement Date (as defined below) and (b) the day immediately before the date of the next annual meeting of stockholders of the Company (or in the event of a merger or consolidation involving the Company in which the Company is a wholly-owned subsidiary immediately following such merger or consolidation, the next annual meeting of stockholders of the Company's parent). The Vesting Commencement Date is January 31, 2021.

Remarks:

Exhibit 24: Power of Attorney